Showing results (321-330 of 373) with videos related to

Sort By:
Pageof 38
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2009
Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infectionDeng-Chyang Wu, Ping-I Hsu, Jeng-Yih Wu, et al.
Gut|June 30, 2022
Autoimmune gastritis: long-term natural history in naïve <i>Helicobacter pylori</i>-negative patientsMassimo Rugge, Ludovica Bricca, Stefano Guzzinati, et al.
The American Journal of Gastroenterology|November 14, 2012
Helicobacter pylori-negative gastritis: prevalence and risk factorsHelena Nordenstedt, David Y Graham, Jennifer R Kramer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2017
Gastric Cancer as Preventable DiseaseMassimo Rugge, Robert M Genta, Francesco Di Mario, et al.
The New England Journal of Medicine|December 14, 2011
Norovirus vaccine against experimental human Norwalk Virus illnessRobert L Atmar, David I Bernstein, Clayton D Harro, et al.
Gut Microbes|January 22, 2019
<i>Bacteroides ovatus</i> ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis modelFaith D Ihekweazu, Tatiana Y Fofanova, Karen Queliza, et al.
Clinical and Vaccine Immunology : CVI|October 5, 2012
Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virusNadim J Ajami, Meagan A Barry, Berenice Carrillo, et al.
Gut|April 12, 2012
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus ReportPeter Malfertheiner, Francis Megraud, Colm A O'Morain, et al.
Gut|February 21, 2024
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updatesMassimo Rugge, Robert M Genta, Peter Malfertheiner, et al.
Frontiers in Immunology|February 2, 2023
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating <i>Helicobacter pylori</i> infection: A prospective, open-labeled, randomized non-inferiority clinical studyYi Hu, Xin Xu, Xiao-Shun Liu, et al.
Pageof 38